Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$100.66 USD

100.66
1,338,879

-0.01 (-0.01%)

Updated Aug 12, 2024 04:00 PM ET

After-Market: $100.64 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (202 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in third-quarter fiscal 2023.

Cardinal Health (CAH) Gains But Lags Market: What You Should Know

Cardinal Health (CAH) closed at $75.50 in the latest trading session, marking a +0.2% move from the prior day.

Cardinal Health (CAH) Outpaces Stock Market Gains: What You Should Know

Cardinal Health (CAH) closed at $75.35 in the latest trading session, marking a +1.01% move from the prior day.

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know

Cardinal (CAH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Cardinal Health (CAH) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Cardinal Health (CAH) closed at $70.37, marking a +1.97% move from the previous day.

Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know

Cardinal Health (CAH) closed the most recent trading day at $69.01, moving -1.33% from the previous trading session.

Cardinal Health (CAH) Gains But Lags Market: What You Should Know

In the latest trading session, Cardinal Health (CAH) closed at $70.51, marking a +0.99% move from the previous day.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock

Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The Zacks Analyst Blog Highlights Cardinal Health, The Coca-Cola, General Mills, The Clorox and Cincinnati Financial

Cardinal Health, The Coca-Cola, General Mills, The Clorox and Cincinnati Financial are part of the Zacks top Analyst Blog.

QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA Approval

QuidelOrtho's (QDEL) receipt of the FDA's De Novo approval is expected to enable it to provide the test as an aid in the diagnosis of SARS-CoV-2 infections in symptomatic individuals.

Nalak Das headshot

5 Safe Stocks to Buy as SVB Collapse Shakes Wall Street

At this stage, it will be prudent to stay with safe stocks.Five such stocks are: CAH, CINF, CLX, KO and GIS.

After Plunging -10.82% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)

Cardinal (CAH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Cardinal Health (CAH) Stock Moves -0.14%: What You Should Know

Cardinal Health (CAH) closed the most recent trading day at $71.19, moving -0.14% from the previous trading session.

Cardinal Health's (CAH) New Tie-Up to Boost Patient Outcomes

Cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offering a more integrated experience that connects all sites of care.

3 Reasons Growth Investors Will Love Cardinal (CAH)

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CVS Health's (CVS) New Acquisitions Aid, Cost Woes Linger

CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.

Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?

Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

IDEXX (IDXX) Global Sales, Instrument Placement Robust

IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.

Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Down

Teleflex (TFX) revenues in Asia rise backed by strong contributions from growth in all geographies.

Chemed (CHE) Q4 Earnings Beat Estimates, Margins Contract

Chemed (CHE) reports impressive sales growth in the Roto-Rooter subsidiary in the fourth quarter of 2022.

NuVasive (NUVA) Q4 Earnings Miss Estimates, Margins Down

Inflationary costs, supply chain disruptions, volatility in foreign exchange rates and the persistent COVID-led impact hurt NuVasive's (NUVA) Q4 revenues.